---
company: Atomera Inc
ticker: ATOM
form: 8-K
filed: 2026-08-04
accession: 0001683168-26-005944
source: https://www.sec.gov/Archives/edgar/data/1420520/000168316826005944/
---

# Atomera (ATOM) earnings release, August 4, 2026

Atomera Inc (ATOM) · Form 8-K, Item 2.02 · Filed 2026-08-04 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1420520/000168316826005944/)

Atomera Provides

Second Quarter 2026 Results

LOS GATOS, Calif.

Aug. 4, 2026

Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the second quarter ended June 30, 2026.

Recent Company Highlights

Management Commentary

“This quarter Atomera made excellent progress with customer engagements across our key target markets, in particular the advanced logic and memory segments where AI is creating the need for further performance improvements,” said Scott Bibaud, president and CEO of Atomera. ” In the past, RF designers have avoided using GaN for high volume applications because of the high cost and complexity of working with GaN on Silicon Carbide. Our breakthrough results with RF GaN on silicon have the potential to enable an entirely new class of RF devices which can now take advantage of the performance improvements

GaN provides with the low cost of silicon substrates.”

Financial Results

The Company incurred a net loss of ($6.3) million, or ($0.17) per basic and diluted share in the second quarter of 2026, compared to a net loss of ($5.0) million, or ($0.17) per basic and diluted share, for the second quarter of 2025. Adjusted EBITDA (a non-GAAP financial measure) in the second quarter of 2026 was a loss of ($5.0) million compared to an adjusted EBITDA loss of ($4.0) million in the second quarter of 2025.

The Company had $38.4 million in cash, cash equivalents, and short-term investment as of June 30, 2026 compared to $19.2 million of cash and cash equivalents as of December 31, 2025.

The total number of shares outstanding was 39.0 million as of June 30, 2026.

Second Quarter 2026 Results Webinar

Atomera will host a live video webinar today to discuss its financial results and recent progress.

Date: Tuesday, Aug. 4, 2026

Time: 2:00 p.m. PT (5:00 p.m. ET)

Webcast: Accessible at https://ir.atomera.com

Note about Non-GAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure.

Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation.

Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company’s internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

About Atomera Incorporated

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon

Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com.

Safe Harbor

This press release contains forward-looking statements concerning Atomera

Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues thus subjecting us to all the risks inherent in an early-stage enterprise;

(2) the risk that licensees or JDA customers do not advance to royalty-based manufacturing and distribution licenses; (3) our ability to add other licensees and/or JDA customers; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and know-how and (6) those other risks disclosed in the section “Risk Factors” included in our Annual Report on

Form 10-K filed with the SEC on February 24, 2026. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur. – Financial Tables Follow – Atomera Incorporated

Condensed Balance Sheets

(in thousands, except per share data)

Atomera Incorporated

Condensed Statements of Operations

(Unaudited)

(in thousands, except per share data)

Atomera Incorporated

Reconciliation to Non-GAAP EBITDA

(Unaudited)

Investor Contact:

Bishop IR

Mike Bishop

(415) 894-9633 investor@atomera.com

## Financial statements

### Income Statement (Three Months Ended — (in thousands, except per share data))

| | Three Months Ended – June 30, – 2026 | Three Months Ended – March 31, – 2026 | Three Months Ended – June 30, – 2025 | Six Months Ended – June 30, – 2026 | Six Months Ended – June 30, – 2025 |
|---|---:|---:|---:|---:|---:|
| Revenue | 158 | 11 | $– | 169 | 4 |
| Cost of revenue | -26 | -126 | -62 | -152 | -62 |
| Gross margin | 132 | -115 | -62 | 17 | -58 |
| Operating expenses | Research and development | 3,287 | 3,457 | 3,004 | 6,744 | 6,259 |
| Operating expenses | General and administrative | 3,167 | 2,333 | 2,048 | 5,500 | 4,136 |
| Operating expenses | Selling and marketing | 437 | 419 | 141 | 856 | 265 |
| Operating expenses | Total operating expenses | 6,891 | 6,209 | 5,193 | 13,100 | 10,660 |
| Operating expenses | Loss from operations | -6,759 | -6,324 | -5,255 | -13,083 | -10,718 |
| Other income (expense) | Interest income | 172 | 197 | 234 | 369 | 504 |
| Other income (expense) | Accretion income | 178 | 57 |  | 235 | 6 |
| Other income (expense) | Interest expense | -1 | -4 | -18 | -5 | -39 |
| Other income (expense) | Other income, net | 74 | 1 | 72 | 75 | 71 |
| Other income (expense) | Total other income (expense), net | 423 | 251 | 288 | 674 | 542 |
| Other income (expense) | Net loss | -6,336 | -6,073 | -4,967 | -12,409 | -10,176 |
| Other income (expense) | Net loss per common share, basic and diluted | -0.17 | -0.17 | -0.17 | -0.34 | -0.34 |
| Other income (expense) | Weighted average number of common shares outstanding, basic and diluted | 38,647 | 35,256 | 30,397 | 36,961 | 30,321 |

### Income Statement (Three Months Ended — (Unaudited))

| | Three Months Ended – June 30, – 2026 | Three Months Ended – March 31, – 2026 | Three Months Ended – June 30, – 2025 | Six Months Ended – June 30, – 2026 | Six Months Ended – June 30, – 2025 |
|---|---:|---:|---:|---:|---:|
| Net loss (GAAP) | -6,336 | -6,073 | -4,967 | -12,409 | -10,176 |
| Depreciation and amortization | 6 | 9 | 12 | 15 | 24 |
| Stock-based compensation | 1,741 | 1,406 | 1,278 | 3,147 | 2,287 |
| Interest income | -172 | -197 | -234 | -369 | -504 |
| Accretion income | -178 | -57 |  | -235 | -6 |
| Interest expense | 1 | 4 | 18 | 5 | 39 |
| Other income, net | -74 | -1 | -72 | -75 | -71 |
| Net loss non-GAAP EBITDA | -5,012 | -4,909 | -3,965 | -9,921 | -8,407 |

### Balance Sheet (December 31, — (in thousands, except per share data))

| | June 30, – 2026 – (Unaudited) | December 31, – 2025 |
|---|---:|---:|
| Current assets: | Cash and cash equivalents | 15,146 | 19,210 |
| Current assets: | Short-term investments | 23,206 |  |
| Current assets: | Interest receivable | 58 | 54 |
| Current assets: | Prepaid expenses and other current assets | 542 | 338 |
| Current assets: | Total current assets | 38,952 | 19,602 |
| Current assets: | Property and equipment, net | 59 | 60 |
| Current assets: | Security deposit | 14 | 14 |
| Current assets: | Operating lease right-of-use asset | 1,128 | 884 |
| Current assets: | Financing lease right-of-use-asset | 70 | 533 |
| Current assets: | Total assets | 40,223 | 21,093 |
| Current liabilities: | Accounts payable | 569 | 608 |
| Current liabilities: | Accrued expenses | 297 | 168 |
| Current liabilities: | Accrued payroll related expenses | 1,118 | 650 |
| Current liabilities: | Current operating lease liability | 304 | 147 |
| Current liabilities: | Current financing lease liability |  | 420 |
| Current liabilities: | Deferred Revenue |  | 7 |
| Current liabilities: | Total current liabilities | 2,288 | 2,000 |
| Current liabilities: | Long-term operating lease liability | 860 | 712 |
| Current liabilities: | Total liabilities | 3,148 | 2,712 |
| Stockholders’ equity: | Common stock: $0.001 par value, authorized 47,500 shares; 39,024 shares issued and outstanding as of June 30, 2026; and 32,354 shares issued and outstanding as of December 31, 2025 | 39 | 32 |
| Stockholders’ equity: | Additional paid in capital | 291,157 | 260,043 |
| Stockholders’ equity: | Other comprehensive income (loss) | -18 |  |
| Stockholders’ equity: | Accumulated deficit | -254,103 | -241,694 |
| Stockholders’ equity: | Total stockholders’ equity | 37,075 | 18,381 |
| Stockholders’ equity: | Total liabilities and stockholders’ equity | 40,223 | 21,093 |
